Vancouver, British Columbia, January 27, 2021 – Beyond Medical Technologies Inc. (“Beyond Medical” or the “Company”) (CSE: DOCT, Frankfurt: 7FM4) applauds President Biden’s actions in his first week as President. Thus far, President Biden has signed two executive orders mandating mask wearing in an effort to prevent the spread of Covid-19.
In his first day of office, President Biden signed an executive order mandating that all individuals on federal lands and in federal buildings must wear masks, keep their physical distance, and follow other public health guidelines. President Biden subsequently signed an additional executive order which requires masks be worn in airports, and on planes, trains, and buses.
Beyond Medical is pleased with President Biden’s efforts to combat Covid-19. Beyond Medical’s wholly-owned subsidiary, Micron Technologies Inc. (“Micron Technologies”), has been operating at full capacity making 3-ply medical grade face masks in Canada. Micron Technologies is currently adding additional manufacturing equipment and plans to submit tenders in the coming weeks to US state governments where medical grade facemasks remain in short supply.
As previously announced, the Company has executed a letter of intent to acquire all of the issued and outstanding securities of Kayan Health Limited (“Kayan Health”). The Company and Kayan Health are currently negotiating the terms of a definitive agreement.
About Beyond Medical
Beyond Medical is an industrial/technology company with a manufacturing facility located in Delta, British Columbia. The Company is developing its Organivore and Pharmavore waste digesters using its proprietary technology. The Company, through its subsidiary Micron Technologies, is also manufacturing medical grade facemasks compliant with ASTM F2100 Standards.
About Kayan Health
Kayan Health’s proprietary AI-powered health communications platform helps doctors streamline communications with their patients and remotely monitor them. Additionally, Kayan Health’s proprietary platform allows patients to schedule virtual consultations with their physicians and communicate with them through chat, audio and video calls. The platform also integrates with wearable devices and diagnostic tools that delivers both patients and doctors with greater visibility into the patient’s health and provides them with proactive automated alerts such as elevated blood pressure and heart rates. Storing all this data in a holistic patient profile that is integrated with the clinic’s electronic health systems – ensuring their patients’ health records are up to date, accessible by all, helps deliver better care and enables clinics to generate more revenue.
Kayan Health’s platform has already been deployed in multiple clinics in the United States and is projected to reach $5M in revenue by 2022. Kayan Health’s proprietary platform was developed by the founders of HeyDoc!, a telehealth app launched in 2016 that had supported over 3,000 patients globally. Kayan Health is a privately held company based in Toronto, Ontario.
For further information contact:
Kal Malhi, CEO
Neither the Canadian Securities Exchange nor its Regulation Services Provider (as that term is defined in the policies of the Canadian Securities Exchange) accepts responsibility for the adequacy or accuracy of this release. The Canadian Securities Exchange has not in any way passed upon the merits of the transactions proposed herein and has neither approved nor disapproved the contents of this press release.
FORWARD LOOKING STATEMENTS:
All information contained in this news release with respect to the Company and Kayan Health was supplied by the parties, respectively, for inclusion herein, and the Company and its respective directors and officers have relied on Kayan Health for any information concerning such party.
This release includes certain statements that may be deemed "forward-looking statements". All statements in this release, other than statements of historical facts, that address events or developments that the Company expects to occur, are forward-looking statements. Forward-looking statements are statements that are not historical facts and are generally, but not always, identified by the words "expects", "plans", "anticipates", "believes", "intends", "estimates", "projects", "potential" and similar expressions, or that events or conditions "will", "would", "may", "could" or "should" occur. Although the Company believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and actual results may differ materially from those in the forward-looking statements. Factors that could cause the actual results to differ materially from those in forward-looking statements include market prices, continued availability of capital and financing, and general economic, market or business conditions. Investors are cautioned that any such statements are not guarantees of future performance and actual results or developments may differ materially from those projected in the forward-looking statements.Forward-looking statements are based on the beliefs, estimates and opinions of the Company's management on the date the statements are made. Except as required by applicable securities laws, the Company undertakes no obligation to update these forward-looking statements in the event that management's beliefs, estimates or opinions, or other factors, should change.
© 2022 Beyond Medical Technologies Inc.